Cellectar Biosciences (CLRB) Stock: Gaining Big on Patent News

By |January 24th, 2017|

Cellectar Biosciences Inc (NASDAQ: CLRB)

Cellectar Biosciences is having an incredibly strong day in the market today, and for good reason. In pre-market hours, it was announced that the company has been awarded a new patent, sending the stock spiking upward dramatically. Below, we’ll talk about the patent, what we saw in the market as […]